Amyloid Plaque Degradation by Matrix Metalloproteinase9
Principal Investigator
Jin-moo Lee, MD, PhD
Washington University in St.Louis
St. Louis, MO, United States
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2006 - March 31, 2008
Grant ID
A2006033
Goals
Since Dr. Alois Alzheimer initially described the disease that bears his names, amyloid plaques have been a hallmark of the disease. Dr. Lee’s team is investigating the role of a specific enzyme believed to be involved in controlling rate of plaque growth. The inquiry into nature’s way of eliminating toxic amyloid will offer scientists new opportunities to leverage this process in future therapeutics.
Summary
One of the major abnormalities found in the brains of patients with Alzheimer’s disease (AD) are clumps of abnormally aggregated protein, called amyloid plaques. These proteins (amyloid-beta peptide) have a remarkable propensity to self-aggregate into long chains of protein known as amyloid fibrils, which are thought to be very resistant to breakdown and clearance. Thus, it is believed that the plaques accumulate in the brains of patients with Alzheimer’s disease, contributing to brain degeneration and leading to dementia. Dr. Lee has recently found an enzyme, matrix metalloproteinase-9 (MMP-9), capable of degrading amyloid fibrils in test tube experiments. He has also found that MMP-9 degrades amyloid plaques in brain slices from a mouse model of AD. Furthermore, he finds that this enzyme is found in cell surrounding amyloid plaques in this mouse model, suggesting that it may play a role in regulating the growth of plaques. In this grant application, Dr. Lee proposes to study the role of MMP-9 in degrading amyloid plaques in a mouse model of Alzheimer’s disease. He plans to use genetically altered AD mice that lack MMP-9 to examine the formation of amyloid plaques, asking the question: “Is plaque formation accelerated in AD mice that lack MMP-9?” Furthermore, this research will determine if MMP-9 limits the size of amyloid plaques once they are formed. Dr. Lee hopes to gain further insight into mechanisms that regulate the growth and degradation of amyloid plaques in Alzheimer’s disease.
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015

Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD